Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to VistaGen Therapeutics for $185,478.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA094793-01 | Phase I | 185,478 | ||||||||
A SBIR Phase II contract was awarded to VistaGen Therapeutics for $1,691,147.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM061468-02A1 | Phase II | 1,691,147 | ||||||||
A SBIR Phase I contract was awarded to VistaGen Therapeutics for $380,752.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS047808-01 | Phase I | 380,752 | ||||||||
A SBIR Phase I contract was awarded to VistaGen Therapeutics from the U.S. Department of Health & Human Services. | SBIR | 2R44GM061468-02A1 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to VistaGen Therapeutics for $219,757.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 219,757 | |||||||||
A SBIR Phase I contract was awarded to VistaGen Therapeutics for $249,754.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 249,754 |